Tellus Therapeutics, Inc. — Form D
Tellus Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-31. The offering totals $75K, of which $75K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-01-31
- Form: D
- Accession: 0001766205-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $75K
- Amount sold: $75K
- Investors: 1
- Date of first sale: 2019-01-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-331815
Issuer
- Name: Tellus Therapeutics, Inc.
- CIK: 0001766205
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 8 DAVIS DRIVE, DURHAM, NC, 27709
- Phone: 919-491-4995
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Jason E Karlic | Director | Hillsborough, NC |
| Alex M Ruckdaeschel | Director | Hillsborough, NC |
| Jason E Karlic | Executive Officer | Hillsborough, NC |
| Chris J Garabedian | Director | Durham, NC |
| Jason E Kralic | Director | Durham, NC |
| Jason E Kralic | Executive Officer | Durham, NC |
| Eric J Benner | Director | Durham, NC |
| Eric J Benner | Executive Officer | Durham, NC |
| Fred J Callori | Director | Durham, NC |
Other filings by this issuer (2)
More